Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders
On December 18, 2024, a meeting of the Expert Council was held to discuss approaches to the treatment of non-specific back pain and pain in rheumatic musculoskeletal disorders. It was noted that non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of therapy for inflammation-related pa...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2025-02-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1712 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839574025662103552 |
|---|---|
| author | A. M. Lila V. A. Parfenov A. E. Karateev T. V. Adasheva L. I. Alekseeva V. V. Afanasyev E. R. Barantsevich O. V. Vorobyeva O. S. Davydov E. V. Ekusheva A. I. Zagrebneva D. A. Iskra M. L. Kukushkin A. P. Rachin E. S. Filatova M. V. Churyukanov V. A. Shirokov |
| author_facet | A. M. Lila V. A. Parfenov A. E. Karateev T. V. Adasheva L. I. Alekseeva V. V. Afanasyev E. R. Barantsevich O. V. Vorobyeva O. S. Davydov E. V. Ekusheva A. I. Zagrebneva D. A. Iskra M. L. Kukushkin A. P. Rachin E. S. Filatova M. V. Churyukanov V. A. Shirokov |
| author_sort | A. M. Lila |
| collection | DOAJ |
| description | On December 18, 2024, a meeting of the Expert Council was held to discuss approaches to the treatment of non-specific back pain and pain in rheumatic musculoskeletal disorders. It was noted that non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of therapy for inflammation-related pain and that optimal therapy should provide a balance between high efficacy and good tolerability in each patient. A new NSAID, pelubiprofen (Pelubio®), has been registered in the Russian Federation. According to research data, its efficacy is comparable to that of non-selective and selective NSAIDs and at the same time the drug has a high safety profile. The resolution of the Expert Council states that this medicine can be prescribed within the framework of Russian clinical practice, considering the registered indications for pelubiprofen and the clinical guidelines adopted in Russia for the treatment of acute and chronic non-specific back pain, radiculopathy, osteoarthritis (including gonarthrosis and coxarthrosis) and rheumatoid arthritis. |
| format | Article |
| id | doaj-art-1ea9a065b956496ab52fe8ac9a08e98c |
| institution | Matheson Library |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2025-02-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-1ea9a065b956496ab52fe8ac9a08e98c2025-08-04T14:00:41ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2025-02-0119111612310.14412/1996-7012-2025-1-116-1232765Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disordersA. M. Lila0V. A. Parfenov1A. E. Karateev2T. V. Adasheva3L. I. Alekseeva4V. V. Afanasyev5E. R. Barantsevich6O. V. Vorobyeva7O. S. Davydov8E. V. Ekusheva9A. I. Zagrebneva10D. A. Iskra11M. L. Kukushkin12A. P. Rachin13E. S. Filatova14M. V. Churyukanov15V. A. Shirokov16V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)V.A. Nasonova Research Institute of RheumatologyRussian University of Medicine, Ministry of Health of RussiaV.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaRussian University of Medicine, Ministry of Health of RussiaAcad. I.P. Pavlov First Saint Petersburg State Medical University of Ministry of Health of RussiaI.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)The Institute of general pathology and pathophysiologyFederal Scientific and Clinical Center for Specialized Medical Care and Medical Technologies of FMBAPirogov Russian National Research Medical University, Ministry of Health of RussiaSaint Petersburg State Pediatric Medical University, Ministry of Health of RussiaThe Institute of general pathology and pathophysiologyNational Association of Comorbid Neurology ExpertsV.A. Nasonova Research Institute of RheumatologyI.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)F.F. Erisman Federal Scientific Center of HygieneOn December 18, 2024, a meeting of the Expert Council was held to discuss approaches to the treatment of non-specific back pain and pain in rheumatic musculoskeletal disorders. It was noted that non-steroidal anti-inflammatory drugs (NSAIDs) remain the mainstay of therapy for inflammation-related pain and that optimal therapy should provide a balance between high efficacy and good tolerability in each patient. A new NSAID, pelubiprofen (Pelubio®), has been registered in the Russian Federation. According to research data, its efficacy is comparable to that of non-selective and selective NSAIDs and at the same time the drug has a high safety profile. The resolution of the Expert Council states that this medicine can be prescribed within the framework of Russian clinical practice, considering the registered indications for pelubiprofen and the clinical guidelines adopted in Russia for the treatment of acute and chronic non-specific back pain, radiculopathy, osteoarthritis (including gonarthrosis and coxarthrosis) and rheumatoid arthritis.https://mrj.ima-press.net/mrj/article/view/1712back paininflammationrheumatoid arthritisosteoarthritisnon-steroidal anti-inflammatory drugspelubiprofenefficacysafety |
| spellingShingle | A. M. Lila V. A. Parfenov A. E. Karateev T. V. Adasheva L. I. Alekseeva V. V. Afanasyev E. R. Barantsevich O. V. Vorobyeva O. S. Davydov E. V. Ekusheva A. I. Zagrebneva D. A. Iskra M. L. Kukushkin A. P. Rachin E. S. Filatova M. V. Churyukanov V. A. Shirokov Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders Современная ревматология back pain inflammation rheumatoid arthritis osteoarthritis non-steroidal anti-inflammatory drugs pelubiprofen efficacy safety |
| title | Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| title_full | Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| title_fullStr | Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| title_full_unstemmed | Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| title_short | Pelubiprofen is a new member of the class of non-steroidal anti-inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| title_sort | pelubiprofen is a new member of the class of non steroidal anti inflammatory drugs for the treatment of back pain and pain in rheumatic musculoskeletal disorders |
| topic | back pain inflammation rheumatoid arthritis osteoarthritis non-steroidal anti-inflammatory drugs pelubiprofen efficacy safety |
| url | https://mrj.ima-press.net/mrj/article/view/1712 |
| work_keys_str_mv | AT amlila pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT vaparfenov pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT aekarateev pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT tvadasheva pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT lialekseeva pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT vvafanasyev pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT erbarantsevich pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT ovvorobyeva pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT osdavydov pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT evekusheva pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT aizagrebneva pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT daiskra pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT mlkukushkin pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT aprachin pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT esfilatova pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT mvchuryukanov pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders AT vashirokov pelubiprofenisanewmemberoftheclassofnonsteroidalantiinflammatorydrugsforthetreatmentofbackpainandpaininrheumaticmusculoskeletaldisorders |